The objective of this study was to characterise the mechanism underlying acquired resistance to temsirolimus, an inhibitor of mammalian target of rapamycin (mTOR), in renal cell carcinoma (RCC).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback